Mezigdomide (CC-92480) Post Idecabtagene Vicleucel in Treating Patients With Relapsed Multiple Myeloma

Clinical trial NCT06048250 · RECRUITING

Trial details

NCT number: NCT06048250
Sponsor: City of Hope Medical Center
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2024-04-09
Primary completion: 2026-09-21
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.